
Adaptam Therapeutics
Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.
About
Adaptam Therapeutics is a biotechnology startup focused on discovering and developing new medicines for patients with rare genetic diseases. Their approach leverages cutting-edge protein degradation technologies to target the underlying causes of these conditions. The company aims to bring innovative therapies to market for previously untreatable diseases.
Similar companies
Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
Shares Biotech, Drug Discovery
Developing novel therapeutics by understanding the complex interplay of biological systems.
Shares Biotech, Drug Discovery
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Shares Biotech, Drug Discovery
Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.
Shares Biotech, Drug Discovery
A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Shares Biotech, Genomics
A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Shares Biotech, Genomics
Key facts
- Website
- adaptamtx.com
- Headquarters
- Cambridge, United States
- Founded
- 2021
- Employees
- 6
- Total funding
- $5M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 27 Oct 2025 | Seed | $3M | Boehringer Ingelheim Venture Fund (BIVF), High-Tech Gründerfonds (HTGF) |
| 18 Apr 2024 | Undisclosed round | Undisclosed | Bioqube Ventures, Light Chain Capital |
| 1 Oct 2023 | Undisclosed round | $2M |
Tech stack
Detected on adaptamtx.com, last scanned 29 Oct 2026. Run your own scan
- Compliance
- GDPR
- Frontend
- jQuery
- SEO
- Rank Math
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Adaptam Therapeutics scores 4. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Adaptam Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Adaptam Therapeutics is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Adaptam Therapeutics raised?
Adaptam Therapeutics has raised a total of $5M in funding. The most recent round on record is Seed.
How many employees does Adaptam Therapeutics have?
Adaptam Therapeutics has approximately 6 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Adaptam Therapeutics

